International Journal of Food Studies
Sign in
Issue image

More articles from Volume 2, Issue 1, 2013

Antioxidants, their properties, uses in food products and their legal implications

The impact of cold chain temperature abuses on the quality of frozen strawberries (Fragaria ×ananassa)

National Food Safety Systems in the European Union: A Comparative Survey

Effect of antioxidant and optimal antimicrobial mixtures of carvacrol, grape seed extract and chitosan on different spoilage microorganisms and their application as coatings on different food matrices

Effect of Biopreservatives on Storage Life of Papaya (Carica papaya L.)

Viability of the microencapsulation of a casein hydrolysate in lipid microparticles of cupuacu butter and stearic acid

Samantha Cristina Pinho ,
Samantha Cristina Pinho
View authors publications

Search this author on:

PubMed | Google Scholar
Janaina Costa Da Silva
Janaina Costa Da Silva
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2012.

Volume 2, Issue 1 (2013)

https://doi.org/10.7455/ijfs.v2i1.125

Abstract

Solid lipid microparticles produced with a mixture of cupuacu butter and stearic acid were used to microencapsulate a commercial casein hydrolysate (Hyprol 8052). The composition of the lipid matrix used for the production of the lipid microparticles was chosen according to data on the wide angle X-ray diffraction (WAXD) and differential scanning calorimetry (DSC) of bulk lipid mixtures, which indicated that the presence of 10 % cupuacu butter was sufficient to significantly change the crystalline arrangement of pure stearic acid. Preliminary tests indicated that a minimum proportion of 4 % of surfactant (polysorbate 80) was necessary to produce empty spherical lipid particles with average diameters below 10 mm. The lipid microparticles were produced using 20 % cupuacu butter and 80 % stearic acid and then stabilized with 4 % of polysorbate 80, exhibiting an encapsulation efficiency of approximately 74 % of the casein hydrolysate. The melting temperature of the casein hydrolysate-loaded lipid microparticles was detected at 65.2 °C, demonstrating that the particles were solid at room temperature as expected and indicating that the incorporation of peptides had not affected their thermal behavior. After 25 days of storage, however, there was a release of approximately 30 % of the initial amount of encapsulated casein hydrolysate. This release was not thought to have been caused by the liberation of encapsulated casein hydrolysate. Instead, it was attributed to the possible desorption of the adsorbed peptides present on the surface of the lipid microparticles.

References

1.
1016, 1758-08-17, SCHERMER (Lukas) †. Art Sales Catalogues Online. Brill;
2.
69. FHD 2007-04-10. KKO:2007:36. Nordisk Domssamling. 2008;50(1).
3.
Aocs. Official Methods and Recommended Practices of the American Oil Chemists. Society. 1998;
4.
Referees 2005–2006 (1/10/05–30/9/06). Transfusion Medicine. 2006;16(6):451–2.
5.
22585, 1855-10-10. Art Sales Catalogues Online. Brill;
6.
Ijfs A. 2013;48–59.
7.
69. FHD 2007-04-10. KKO:2007:36. Nordisk Domssamling. 2008;50(1).
8.
Volume 1886 - Issue 1002 (1886-10-06). The North China Herald Online. Brill;
9.
Clemente A. Enzymatic protein hydrolysates in human nutrition. Trends in Food Science & Technology. 2000;11(7):254–62.
10.
10/2004. Schweizer Archiv für Tierheilkunde. 2004;146(10):487–94.
11.
Piccini A. CSF Biomarkers~!2009-10-10~!2010-01-21~!2010-05-06~! The Open Nuclear Medicine Journal. 2010;2(2):25–30.
12.
JDS expect 10-15% decline in Q4. III-Vs Review. 2001;14(9):4.
13.
1016, 1758-08-17, SCHERMER (Lukas) †. Art Sales Catalogues Online. Brill;
14.
10/2009. Schweizer Archiv für Tierheilkunde. 2009;151(10):507–8.
15.
Referees 2005–2006 (1/10/05–30/9/06). Transfusion Medicine. 2006;16(6):451–2.
16.
Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Current Opinion in Biotechnology. 2007;18(2):163–9.
17.
Piccini A. CSF Biomarkers~!2009-10-10~!2010-01-21~!2010-05-06~! The Open Nuclear Medicine Journal. 2010;2(2):25–30.
18.
Volume 1909 - Issue 2174 (1909-04-10). The North China Herald Online. Brill;
19.
Sobue S ichi, Sasaki S, Kato M, Maejima H, Minamino H, Konishi H, et al. The Result of SELENE (KAGUYA) Development and Operation~!2009-06-28~!2009-08-10~!2009-10-01~! Recent Patents on Space Technology. 2009;1(1):12–23.
20.
Lairon D. Digestion and absorption of lipids. 2009;66–93.
21.
Lannes S, Medeiros M, Gioielli L. Rheological properties of cupuassu and cocoa butters. Grasas y Aceites. 2004;(2):115–21.
22.
Lee Y, Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Advanced Drug Delivery Reviews. 1989;(2):171–207.
23.
1915-06-17-DE-003. The Armenian Genocide. Berghahn Books; 2013. p. 210–1.
24.
1915-06-22-DE-002. The Armenian Genocide. Berghahn Books; 2013. p. 214–5.
25.
Thebault V. 3841. The American Mathematical Monthly. 1939;46(9):606.
26.
Piccini A. CSF Biomarkers~!2009-10-10~!2010-01-21~!2010-05-06~! The Open Nuclear Medicine Journal. 2010;2(2):25–30.
27.
Volume 1887 - Issue 1016 (1887-01-12). The North China Herald Online. Brill;
28.
Piccini A. CSF Biomarkers~!2009-10-10~!2010-01-21~!2010-05-06~! The Open Nuclear Medicine Journal. 2010;2(2):25–30.
29.
1016, 1758-08-17, SCHERMER (Lukas) †. Art Sales Catalogues Online. Brill;
30.
Mikkelsen T, Rasmussen E, Olsen A, Barkholt V, Frokiaer H. Immunogenicity of kappa-casein and glycomacropeptide. Journal of Dairy Science. 2006;(3):824–30.
31.
Hyzy P, Bijak M. Kongressbericht ICMART XIII World Congress 2008 10.-12. Oktober 2008 Budapest. Deutsche Zeitschrift für Akupunktur. 2009;52(1):83–4.
32.
Kiningham RB. 1039. Medicine & Science in Sports & Exercise. 2008;40(5):S121.
33.
Nicholson JW, Bennett AA. 3109. The American Mathematical Monthly. 1925;32(8):436.
34.
Mazel M. 1016. Critical Care Medicine. 2012;40:1–328.
35.
Barra J. Erratum to Book reviews1PII of original article: S0939-6411(97)00075-1.1. European Journal of Pharmaceutics and Biopharmaceutics. 1998;45(2):209.
36.
10. Flight 007. The Rhetorical Rise and Demise of “Democracy” in Russian Political Discourse. Academic Studies Press; 2021. p. 188–94.
37.
Osborn H, Akoh C. 2002;93–103.
38.
Referees 2005–2006 (1/10/05–30/9/06). Transfusion Medicine. 2006;16(6):451–2.
39.
Cardarelli GA. 2697. International Journal of Radiation Oncology*Biology*Physics. 2006;66(3):S596–7.
40.
Szakmany T, Ellis G, Sharif B, Lundin R, Morgan P, Hall J. 1021. Critical Care Medicine. 2015;43:257.
41.
Ijfs A. 2013;48–59.
42.
03/2011. Schweizer Archiv für Tierheilkunde. 2011;153(3):141–141.
43.
Shaji J, Patole V. Protein and Peptide Drug Delivery: Oral Approaches. Indian Journal of Pharmaceutical Sciences. 2008;(3):269–77.
44.
Szakmany T, Ellis G, Sharif B, Lundin R, Morgan P, Hall J. 1021. Critical Care Medicine. 2015;43:257.
45.
Piccini A. CSF Biomarkers~!2009-10-10~!2010-01-21~!2010-05-06~! The Open Nuclear Medicine Journal. 2010;2(2):25–30.
46.
SPIE P of. Front Matter: Volume 7827. Vol. 7827, SPIE Proceedings. SPIE; 2010. p. 782701.
47.
10.1007/s11489-008-1007-2. CrossRef Listing of Deleted DOIs. 2010;
48.
Yokota D, Moraes M, Pinho S. Characterization of lyophilized liposomes produced with non-purified soy lecithin: A case study of casein hydrolysate microencapsulation. Brazilian Journal of Chemical Engineering. 2012;(2):325–35.
49.
Ijfs A. 2013;48–59.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
Scopus
DOAJ
Sherpa-Romero
Google Scholar
Crossref